Search results
Jun 26, 2024 · “It has become increasingly apparent that a new, more powerful class of anti-malarials is needed, especially to combat severe malaria,” said Dr. Jonathan Kurtis, one of Ocean’s Scientific Co-Founders.
Jun 10, 2024 · Jonathan Kurtis, M.D., Ph.D. Title: Professor. Institution: Brown University. Location: Rhode Island. Subspecialties: Blood bank / transfusion medicine, Clinical pathology. Status: Staff. Email: jonathan_kurtis@brown.edu. Consultations: No. Focus Groups: No. Website Doximity ResearchGate. QR code. Home > Directory > Jonathan Kurtis, M.D., Ph.D.
5 days ago · Ocean Biomedical (NASDAQ: OCEA) Will Host an R&D Update Today on Malaria, and Fibrosis Programs with Scientific Co-founders Jack A. Elias, MD, and Jonathan Kurtis, MD PhD. Presentation will be hosted live on Ocean Biomedical's Youtube Channel at 2:00pm ET
- 3.91
- 98.59M
- 48.16M
- 34.65M
Jun 19, 2024 · OCEA Ocean Biomedical Inc Ocean Biomedical (NASDAQ: OCEA) Will Host an R&D Update Today on Malaria, and Fibrosis Programs with Scientific Co-founders Jack A. Elias, MD, and Jonathan Kurtis,...
5 days ago · Statement of acquisition of beneficial ownership by individuals. Company profile for Ocean Biomedical, Inc. (OCEA) with a description, list of executives, contact details and other key facts.
2 days ago · REUTERS. 5. Dr. Kevin Cannard, a Parkinson’s disease specialist, met with President Biden’s personal physician at the White House in January. The fourth person has not been identified in the ...
Jul 2, 2024 · Ocean Biomedical (NASDAQ: OCEA) Announces $1 Million Falk Award for Malaria Drug Candidate Addressing Evolving Resistance to Artemisinin-Based Therapeutics to Chief Scientist Dr. Jonathan Kurtis. By Marketwired • 10-24-2023